Acciones Tobira Therapeutics Inc Nasdaq
Acciones
US75874Q1076
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 53 | - |
Scott Reents
DFI | Director of Finance/CFO | 57 | - |
Corporate Secretary | - | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,37 % | 122 mil M | |
+19,45 % | 115 mil M | |
+21,22 % | 26,64 mil M | |
-23,62 % | 19,91 mil M | |
-17,47 % | 16,32 mil M | |
-45,95 % | 15,52 mil M | |
-18,52 % | 15,49 mil M | |
+62,37 % | 14,83 mil M | |
+1,98 % | 13,67 mil M |